Should I buy or sell Outset Medical stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares. View OM analyst ratings or view top-rated stocks .

What is Outset Medical's stock price target for 2024?

6 equities research analysts have issued 12 month target prices for Outset Medical's stock. Their OM share price targets range from $3.00 to $6.00. On average, they predict the company's share price to reach $5.42 in the next year. This suggests a possible upside of 165.5% from the stock's current price. View analysts price targets for OM or view top-rated stocks among Wall Street analysts .

How have OM shares performed in 2024?

Outset Medical's stock was trading at $5.41 on January 1st, 2024. Since then, OM stock has decreased by 62.3% and is now trading at $2.04. View the best growth stocks for 2024 here .

When is Outset Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our OM earnings forecast .

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) issued its quarterly earnings results on Wednesday, February, 21st. The company reported ($0.77) EPS for the quarter, missing the consensus estimate of ($0.74) by $0.03. The firm earned $30.51 million during the quarter, compared to analyst estimates of $30.40 million. Outset Medical had a negative net margin of 132.54% and a negative trailing twelve-month return on equity of 102.50%.

What ETFs hold Outset Medical's stock?

ETFs with the largest weight of Outset Medical (NASDAQ:OM) stock in their portfolio include Procure Disaster Recovery Strategy ETF (FIXT) , Procure Disaster Recovery Strategy ETF (FEMA) , BNY Mellon Innovators ETF (BKIV) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) . iShares U.S. Medical Devices ETF (IHI) .

What guidance has Outset Medical issued on next quarter's earnings?

Outset Medical updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $145.0 million-$153.0 million, compared to the consensus revenue estimate of $148.8 million.

When did Outset Medical IPO?

Outset Medical (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

How do I buy shares of Outset Medical?

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:OM

Outset Medical (OM) Stock Price, News & Analysis

→ A.I. “Perfect Storm” Could Send THESE Stocks Sky High (From InvestorPlace) (Ad)

Free OM Stock Alerts

$2.04

-0.01 (-0.49%)

(As of 04/15/2024 ET)

Compare

Today's Range: $1.92
▼
$2.11
50-Day Range: $1.94
▼
$3.79
52-Week Range: $1.92
▼
$24.13

Volume: 1.09 million shs
Average Volume: 992,492 shs
Market Capitalization: $105.47 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.42

Get Outset Medical alerts:

Outset Medical MarketRank™ Stock Analysis

Analyst Rating: Hold
2.33 Rating Score
Upside/Downside: 165.5% Upside
$5.42 Price Target
Short Interest: Bearish
16.17% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.62
Based on 3 Articles This Week
Insider Trading: Selling Shares
$416,371 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($2.28) to ($2.23) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.76 out of 5 stars

Medical Sector

659th out of 928 stocks

Electromedical Equipment Industry

12th out of 18 stocks

3.2

Analyst's Opinion

Consensus Rating
Outset Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 2 hold ratings, and 1 sell rating.
Amount of Analyst Coverage
Outset Medical has only been the subject of 2 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
16.17% of the outstanding shares of Outset Medical have been sold short.
Short Interest Ratio / Days to Cover
Outset Medical has a short interest ratio ("days to cover") of 8.2.
Change versus previous month
Short interest in Outset Medical has recently decreased by 1.88%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Outset Medical does not currently pay a dividend.
Dividend Growth
Outset Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OM.

2.6

News and Social Media Coverage

News Sentiment
Outset Medical has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Outset Medical this week, compared to 2 articles on an average week.
Search Interest
Only 5 people have searched for OM on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.
MarketBeat Follows
5 people have added Outset Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $416,371.00 in company stock.
Percentage Held by Insiders
Only 4.00% of the stock of Outset Medical is held by insiders.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Outset Medical are expected to grow in the coming year, from ($2.28) to ($2.23) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Outset Medical is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Outset Medical is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Outset Medical has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About Outset Medical Stock (NASDAQ:OM)

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

OM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OM Stock News Headlines

April 15, 2024 | businesswire.com

Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care

April 9, 2024 | investing.com

Outset Medical shares get Buy rating from BTIG

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

April 9, 2024 | americanbankingnews.com

BTIG Research Begins Coverage on Outset Medical (NASDAQ:OM)

April 8, 2024 | msn.com

Buy Rating And Bullish Price Target Sends Small Cap Soaring

April 8, 2024 | markets.businessinsider.com

Outset Medical: Overcoming Challenges with Strong Market Potential and Recurring Revenue Growth

April 6, 2024 | americanbankingnews.com

Outset Medical (NASDAQ:OM) Upgraded to Buy by CL King

March 18, 2024 | msn.com

Care Plan Your Doctor Would Usually Recommend For Acute Otitis Media

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

March 13, 2024 | businesswire.com

Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors

March 6, 2024 | wsj.com

Why Dialysis Stocks Are up Today

February 26, 2024 | businesswire.com

Outset Medical to Present at the 44th Annual TD Cowen Health Care Conference

February 23, 2024 | finance.yahoo.com

Outset Medical Full Year 2023 Earnings: EPS Misses Expectations

February 22, 2024 | markets.businessinsider.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Outset Medical (OM)

February 22, 2024 | finance.yahoo.com

Outset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call Transcript

February 22, 2024 | finance.yahoo.com

Q4 2023 Outset Medical Inc Earnings Call

February 21, 2024 | msn.com

Outset Medical beats top-line and bottom-line estimates; reaffirms FY24 outlook

February 21, 2024 | finance.yahoo.com

Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results

February 21, 2024 | finance.yahoo.com

Outset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 Results

February 21, 2024 | businesswire.com

Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results

February 20, 2024 | msn.com

Outset Medical Q4 2023 Earnings Preview

February 17, 2024 | finance.yahoo.com

OM Mar 2024 4.000 put

February 14, 2024 | investing.com

Outset Medical Inc (OM)

February 5, 2024 | finance.yahoo.com

Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?

February 5, 2024 | finance.yahoo.com

Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024

January 13, 2024 | benzinga.com

Outset Medical Stock (NASDAQ:OM), Short Interest Report

January 12, 2024 | msn.com

Outset Medical downgraded at RBC citing a difficult 2024

See More Headlines

Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/21/2024
Today: 4/16/2024
Next Earnings (Estimated): 5/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:OM
CUSIP: N/A
CIK: 1484612
Web: outsetmedical.com
Phone: 669-231-8200
Fax: N/A
Employees: 480
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $5.42
High Stock Price Target: $6.00
Low Stock Price Target: $3.00
Potential Upside/Downside: +165.5%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.50)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-172,800,000.00
Net Margins: -132.54%
Pretax Margin: -132.14%
Return on Equity: -102.50%
Return on Assets: -52.42%

Debt

Debt-to-Equity Ratio: 1.06
Current Ratio: 5.26
Quick Ratio: 4.37

Sales & Book Value

Annual Sales: $130.38 million
Price / Sales: 0.81
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.45 per share
Price / Book: 0.83

Miscellaneous

Outstanding Shares: 51,700,000
Free Float: 49,634,000
Market Cap: $105.47 million
Optionable: Not Optionable
Beta: 1.99

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Ms. Leslie L. Trigg (Age 53)
President, CEO & Chairman
Comp: $1.22M
Mr. Nabeel Ahmed (Age 48)
Chief Financial Officer
Comp: $654.74k
Mr. John L. Brottem (Age 49)
General Counsel & Secretary
Comp: $594.15k
Mr. Marc Nash (Age 35)
Senior Vice President of Operations and R&D
Mr. Jean-Olivier Racine (Age 42)
Chief Technology Officer
Comp: $540.93k
Mr. James S. Mazzola
Head of Investor Relations
Nicole Shannon
Director of Marketing Communications
Dr. Michael Aragon M.D.
Chief Medical Officer
Mr. Mark Gordon M.S. (Age 67)
Chief Regulatory & Quality Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

OM Stock Analysis - Frequently Asked Questions

Should I buy or sell Outset Medical stock right now?: 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares.
View OM analyst ratings or view top-rated stocks.
What is Outset Medical's stock price target for 2024?: 6 equities research analysts have issued 12 month target prices for Outset Medical's stock. Their OM share price targets range from $3.00 to $6.00. On average, they predict the company's share price to reach $5.42 in the next year. This suggests a possible upside of 165.5% from the stock's current price.
View analysts price targets for OM or view top-rated stocks among Wall Street analysts.
How have OM shares performed in 2024?: Outset Medical's stock was trading at $5.41 on January 1st, 2024. Since then, OM stock has decreased by 62.3% and is now trading at $2.04.
View the best growth stocks for 2024 here.
When is Outset Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our OM earnings forecast.
How were Outset Medical's earnings last quarter?: Outset Medical, Inc. (NASDAQ:OM) issued its quarterly earnings results on Wednesday, February, 21st. The company reported ($0.77) EPS for the quarter, missing the consensus estimate of ($0.74) by $0.03. The firm earned $30.51 million during the quarter, compared to analyst estimates of $30.40 million. Outset Medical had a negative net margin of 132.54% and a negative trailing twelve-month return on equity of 102.50%.

What ETFs hold Outset Medical's stock?: ETFs with the largest weight of Outset Medical (NASDAQ:OM) stock in their portfolio include Procure Disaster Recovery Strategy ETF (FIXT), Procure Disaster Recovery Strategy ETF (FEMA), BNY Mellon Innovators ETF (BKIV) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Medical Devices ETF (IHI).
What guidance has Outset Medical issued on next quarter's earnings?: Outset Medical updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $145.0 million-$153.0 million, compared to the consensus revenue estimate of $148.8 million.
When did Outset Medical IPO?: Outset Medical (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.
How do I buy shares of Outset Medical?: Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OM) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial